Invega Trinza

Active Ingredient(s): Paliperidone Palmitate
FDA Approved: * May 18, 2015
Pharm Company: * JANSSEN PHARMS
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Invega Trinza Overview

Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester indicated for once-every 28 days injection after an ini...

Read more Invega Trinza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Paliperidone

Recent Invega Trinza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Paliperidone Palmitate
  • Suspension, Extended Release: 117mg/0.75ml (117mg/0.75ml), 156mg/ml (156mg/ml), 234mg/1.5ml (156mg/ml), 273mg/0.875ml (273mg/0.875ml), 39mg/0.25ml (39mg/0.25ml), 410mg/1.315ml (311.79mg/ml), 546mg/1.75ml (312mg/ml), 78mg/0.5ml (78mg/0.5ml), 819mg/2.625ml (312mg/ml)
  • Suspension, Extended-release: 273mg, 410mg, 546mg, 819mg
  • Tablet, Extended Release: 1.5mg, 12mg, 3mg, 6mg, 9mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Invega Trinza: (4 results)

Sorted by National Drug Code
  • 50458-606 Invega Trinza 273 mg/.875ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc
  • 50458-607 Invega Trinza 410 mg/1.315ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc
  • 50458-608 Invega Trinza 546 mg/1.75ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc
  • 50458-609 Invega Trinza 819 mg/2.625ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc

Other drugs which contain Paliperidone Palmitate or a similar ingredient: (3 results)

Related Invega Trinza Topics:

invega sustenna is poison
I was forced 6 injections. I'm dying from it. IT is the worst torturous death you can imagine. over 50 side effects.... 17 replies
invega sustenna side effects
After my serious episode they started me on 156 invega sustenna injection. Lets see the first 2 weeks I am extremely tir... 7 replies
invega sustenna
Can it be dangerous to take invega sustenna? ## as far as I know, 4.5% in comparison to 2.6 % on placebo died, but not s... 7 replies
invega uses
My friends daughter was just put on this drug when she had a psychotic break and was hospitalized. My friend said they h... 6 replies
Invega problems
I have been taking invega 3mg for about a year, and have started feeling like my heart is fluttering. I also got to the ... 5 replies
Invega and weight gain
This is my story: I've been taking Invega since 2013. I read dozens of pages on the Internet and they say it causes ... 2 replies
Invega withdrawal
So I took the invega shot one time. I never went back a week later to get the other dose. I'm not schizophrenic I do... 2 replies
Invega horrible drug.
I was given two shots of invega sustenna, the 234mg loading dose and then the 154mg starting does and it as been the mos... 2 replies
Invega: Increasing dosage, pills or inj.
I have been taking Invega in pill form. I started at 3mg. 3 months ago. Recently this was upped to 6 and now am taking 9... 1 reply
invega hair loss
I took invega once 2 months ago. Now it's thinning the back of my hair. Will it ever restore again? Thank you. ## He... 1 reply






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA